What happened in the Ready for the World trademark lawsuit?

Michigan federal court dismissed the suit on September 9, ruling ex-members Melvin Riley and John Eaton are still co-owners via tax forms and no ownership transfer.

Can leaving a band end your trademark ownership?

Not automatically—the court said band membership and corporate/trademark ownership are separate; proof like K-1 shares trumps departure.

Does this affect concert promoters in band IP disputes?

Out-of-state promoters can dodge jurisdiction without purposeful Michigan ties, as seen with California nonprofit CCPA.

©️ IP & Copyright

Band Split Drama: Court Says Leaving Ready for the World Didn't Strip Away Trademark Rights

Imagine jamming on stage one night, then fighting over the band name forever. That's the wild reality for Ready for the World's original members, as a Michigan court just ruled their trademark ties endure post-split.

theAIcatchup Apr 09, 2026 4 min read

80s R&B band Ready for the World members on stage with microphone and legal gavel overlay

⚡ Key Takeaways

Tax forms like Schedule K-1 proved co-ownership, trumping bylaws and band splits. 𝕏
Band and corporate/trademark entities are legally distinct—leaving one doesn't forfeit the other. 𝕏
Jurisdiction fails without purposeful ties to the forum state, shielding distant promoters. 𝕏

Published by

theAIcatchup

Where law meets technology.

#Lanham Act #Lanham Act dismissal #band IP dispute #band disputes #co-ownership ruling #music trademarks #trademark infringement

Worth sharing?

Get the best Legal Tech stories of the week in your inbox — no noise, no spam.

Originally reported by IPWatchdog

⚡ Key Takeaways

The 60-Second TL;DR

theAIcatchup

Share this article

Worth sharing?

Related Stories

Examiners' Secret Weapon: 25% of Patent Rejections Cite Invisible Prior Art

Federal Circuit's Nexus Ratchet Meets Its Match: Printed Matter's Symmetry Test

85% of PTAB Patents Face Parallel Court Battles: Congress's AIA Tilted the Scales

Eli Lilly Joins Sanofi Onslaught as Amgen's Broad Patent Claims Face SCOTUS Scrutiny

Stay in the loop